{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:28:38Z","timestamp":1792222118870,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":317,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023094","name":"Saint Joseph's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R15AR069935"],"award-info":[{"award-number":["R15AR069935"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016221","name":"Rowan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031445","name":"New Jersey Commission on Cancer Research","doi-asserted-by":"publisher","award":["COCR22RBG007"],"award-info":[{"award-number":["COCR22RBG007"]}],"id":[{"id":"10.13039\/100031445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031445","name":"New Jersey Commission on Cancer Research","doi-asserted-by":"publisher","award":["COCR25PRF018"],"award-info":[{"award-number":["COCR25PRF018"]}],"id":[{"id":"10.13039\/100031445","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.101037","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:56:28Z","timestamp":1763628988000},"page":"101037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Emerin expression stratification across breast cancer subtypes"],"prefix":"10.1016","volume":"45","author":[{"given":"Thaysa","family":"Ghiarone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9358-9592","authenticated-orcid":false,"given":"Emily","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Holaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2025.101037_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1582-4934.2007.00176.x","article-title":"Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem","volume":"12","author":"Bussolati","year":"2008","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2025.101037_bib0002","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/c5ib00040h","article-title":"Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration","volume":"7","author":"Acerbi","year":"2015","journal-title":"Integr. Biol. (Camb)"},{"issue":"2","key":"10.1016\/j.ctarc.2025.101037_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00418-013-1151-4","article-title":"Analysis of nuclear actin by overexpression of wild-type and actin mutant proteins","volume":"141","author":"Kokai","year":"2014","journal-title":"Histochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101037_bib0004","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tcb.2016.03.007","article-title":"Force matters: biomechanical regulation of cell invasion and migration in disease","volume":"26","author":"Kai","year":"2016","journal-title":"Trends. Cell Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2025.101037_bib0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101037_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ctarc.2025.101037_bib0007","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3389\/fonc.2019.01376","article-title":"The extracellular, cellular, and nuclear stiffness, a trinity in the cancer resistome-A review","volume":"9","author":"Deville","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2025.101037_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fonc.2018.00145","article-title":"Cell adhesion and matrix stiffness: coordinating cancer Cell invasion and metastasis","volume":"8","author":"Gkretsi","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101037_bib0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41567-019-0680-8","article-title":"Cell swelling, softening and invasion in a three-dimensional breast cancer model","volume":"16","author":"Han","year":"2020","journal-title":"Nat. Phys."},{"key":"10.1016\/j.ctarc.2025.101037_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18632\/oncotarget.28375","article-title":"The nuclear envelope and metastasis","volume":"14","author":"Hansen","year":"2023","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.ctarc.2025.101037_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011289","article-title":"The role of emerin in cancer progression and metastasis","volume":"22","author":"Liddane","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101037_bib0012","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-20-0413","article-title":"Defects in emerin-nucleoskeleton binding disrupt nuclear structure and promote breast cancer cell motility and metastasis","volume":"19","author":"Liddane","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101037_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70752-5","article-title":"Emerin deficiency drives MCF7 cells to an invasive phenotype","volume":"14","author":"Hansen","year":"2024","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ctarc.2025.101037_bib0014","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1158\/0008-5472.CAN-18-0608","article-title":"Emerin deregulation links nuclear shape instability to metastatic potential","volume":"78","author":"Reis-Sobreiro","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2025.101037_bib0015","article-title":"Metabolomics in hepatocellular carcinoma: from biomarker discovery to precision medicine","volume":"4","author":"Wu","year":"2022","journal-title":"Front. Med. Technol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101037_bib0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4149\/neo_2021_210728N1059","article-title":"Emerin knockdown induces the migration and invasion of hepatocellular carcinoma cells by up-regulating the cytoplasmic p21","volume":"69","author":"Wu","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.ctarc.2025.101037_bib0017","article-title":"Emerin dysregulation drives the very-small-nuclear phenotype and lineage plasticity that associates with a clinically aggressive subtype of prostate cancer","author":"Zhang","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.ctarc.2025.101037_bib0018","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1128\/MCB.00087-09","article-title":"Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer","volume":"29","author":"CD","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ctarc.2025.101037_bib0019","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-9-28","article-title":"Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer","volume":"9","author":"Capo-chichi","year":"2011","journal-title":"BMC. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2025.101037_bib0020","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.celrep.2016.11.022","article-title":"Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition","volume":"17","author":"Comaills","year":"2016","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101037_bib0021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrc3219","article-title":"The nuclear envelope environment and its cancer connections","volume":"12","author":"Chow","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2025.101037_bib0022","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/jcp.2003.010777","article-title":"Prognostic value of proliferation in invasive breast cancer: a review","volume":"57","author":"van Diest","year":"2004","journal-title":"J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.ctarc.2025.101037_bib0023","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5732\/cjc.010.10566","article-title":"Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer","volume":"30","author":"Capo-chichi","year":"2011","journal-title":"Chin. J. Cancer"},{"issue":"36","key":"10.1016\/j.ctarc.2025.101037_bib0024","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/s41388-022-02420-9","article-title":"Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer","volume":"41","author":"Bell","year":"2022","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.ctarc.2025.101037_bib0025","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259493","article-title":"Emerin regulation of nuclear stiffness is required for fast amoeboid migration in confined environments","volume":"135","author":"Lavenus","year":"2022","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2025.101037_bib0026","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1529\/biophysj.104.045476","article-title":"Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence","volume":"88","author":"Guck","year":"2005","journal-title":"Biophys. J."},{"issue":"12","key":"10.1016\/j.ctarc.2025.101037_bib0027","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nnano.2007.397","article-title":"Nanomedicine: elastic clues in cancer detection","volume":"2","author":"Suresh","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101037_bib0028","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500323","article-title":"The role of inner nuclear membrane protein emerin in myogenesis","volume":"39","author":"Marano","year":"2025","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101037_bib0029","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s12276-024-01308-w","article-title":"Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment","volume":"56","author":"Popeda","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.ctarc.2025.101037_bib0030","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/CAD.0000000000000123","article-title":"The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes","volume":"25","author":"Stathopoulos","year":"2014","journal-title":"Anticancer Drugs"},{"issue":"17","key":"10.1016\/j.ctarc.2025.101037_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174455","article-title":"Ki-67 as a prognostic biomarker in invasive breast cancer","volume":"13","author":"Davey","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctarc.2025.101037_bib0032","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E., Anchondo-Nunez P., Acuna-Aguilar L.E., Gomez-Valles F.O., Ramirez-Valdespino C.A. Subtypes of breast cancer. In: Mayrovitz H.N., Ed.. Breast Cancer. Brisbane (AU) 2022.","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"10.1016\/j.ctarc.2025.101037_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231187201","article-title":"Evolving perspectives on the treatment of HR+\/HER2+ metastatic breast cancer","volume":"15","author":"Pegram","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101037_bib0034","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3892\/ol.2016.4199","article-title":"Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer","volume":"11","author":"Yuan","year":"2016","journal-title":"Oncol. Lett."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422500173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422500173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:14:11Z","timestamp":1773818051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422500173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"alternative-id":["S246829422500173X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101037","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerin expression stratification across breast cancer subtypes","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101037"}}